SEC Form 4/A · accession 0001104659-18-004813
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Enrique J. Carrazana
Director
Period of report
Jan 17, 2017
Accepted (ET)
Jan 29, 2018 · 8:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jan 17, 2017 | A | 28,500 | — | A | 31,800 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted common stock. All shares of restricted common stock vest on 1/17/18. This amendment is being filed to correct the reporting of restricted stock grants moving the report of grant of the restricted stock from Table II to Table I of the report being amended.